Eloxx Pharmaceuticals Stock Target Price
ELOXDelisted Stock | USD 6.12 0.30 4.67% |
Eloxx Pharmaceuticals fundamentals help investors to digest information that contributes to Eloxx Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Eloxx Pink Sheet. The fundamental analysis module provides a way to measure Eloxx Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eloxx Pharmaceuticals pink sheet.
Eloxx |
Eloxx Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eloxx Pharmaceuticals' direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Eloxx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eloxx Pharmaceuticals by comparing valuation metrics of similar companies.Eloxx Pharmaceuticals is currently under evaluation in target price category among its peers.
Eloxx Fundamentals
Return On Equity | -6.15 | ||||
Return On Asset | -0.73 | ||||
Current Valuation | 30.28 M | ||||
Shares Outstanding | 2.75 M | ||||
Shares Owned By Insiders | 0.59 % | ||||
Shares Owned By Institutions | 37.06 % | ||||
Number Of Shares Shorted | 21.48 K | ||||
Price To Earning | (7.94) X | ||||
Price To Book | 6.31 X | ||||
EBITDA | (34.42 M) | ||||
Net Income | (36.06 M) | ||||
Cash And Equivalents | 30.05 M | ||||
Cash Per Share | 0.35 X | ||||
Total Debt | 13.38 M | ||||
Current Ratio | 1.62 X | ||||
Book Value Per Share | (7.46) X | ||||
Cash Flow From Operations | (31.84 M) | ||||
Short Ratio | 0.20 X | ||||
Earnings Per Share | (12.93) X | ||||
Target Price | 55.0 | ||||
Number Of Employees | 18 | ||||
Beta | 2.68 | ||||
Market Capitalization | 14.86 M | ||||
Total Asset | 21.12 M | ||||
Retained Earnings | (274.39 M) | ||||
Working Capital | (2.96 M) | ||||
Current Asset | 3.84 M | ||||
Current Liabilities | 840.05 K | ||||
Z Score | -23.07 | ||||
Net Asset | 21.12 M |
About Eloxx Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eloxx Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eloxx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eloxx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Eloxx Pink Sheet
If you are still planning to invest in Eloxx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eloxx Pharmaceuticals' history and understand the potential risks before investing.
Transaction History View history of all your transactions and understand their impact on performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |